Discovery of a Potent and Selective Protein Kinase CK2 Inhibitor by High-Throughput Docking
Author:
Affiliation:
1. Oncology Research, Novartis Pharma AG, 4002 Basle, Switzerland, and Nervous System Research, Novartis Pharma AG, CH-4002 Basle, Switzerland, and Process R&D, Novartis Pharma AG, CH-4002 Basle, Switzerland
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm030827e
Reference41 articles.
1. Protein kinase CK2: a challenge to canons
2. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
3. Joining the cell survival squad: an emerging role for protein kinase CK2
4. Protein kinase CK2 and its role in cellular proliferation, development and pathology
Cited by 205 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TMSOTf-Catalyzed Reactions of N-Arylynamides with Sulfilimines To Construct 2-Aminoindoles and α-Arylated Amidines;The Journal of Organic Chemistry;2024-01-05
2. Easy Access to Phenanthridinones via Metal-Free Cascade Benzannulation and C–N Bond Formation;Organic Letters;2023-11-16
3. Synthesis of Luminescent Indolo[2,1-b]quinazolin-6(12H)-ones via a Sequential Ugi/Iodine-Promoted Cyclization/Staudinger/Aza-Wittig Reaction;The Journal of Organic Chemistry;2023-11-09
4. Exploring Protein Kinase CK2 Substrate Recognition and the Dynamic Response of Substrate Phosphorylation to Kinase Modulation;Kinases and Phosphatases;2023-10-07
5. Structure-guided discovery of adenosine triphosphate-competitive casein kinase 2 inhibitors;Future Medicinal Chemistry;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3